Oral Antibiotics in Germany and the Netherlands in Primary Care from 2012

Oral Antibiotics in Germany and the Netherlands in Primary Care from 2012 – 2016: A Comparison

Gradl G Teichert M Kieble M Werning J Schulz M

Poster 46th ESCP Symposium on Clinical Pharmacy (Best Poster Award).
Heidelberg, 09.-11.10.2017. Programme and Abstract Book PE007, p. 166
Int. J. Clin. Pharm. 40, 1 (2018) 295.

ESCP-2017_Poster_PE007_Oral_antibiotics

Interessenskonflikte: none declared

Anwendung pharmazeutischer Bedenken 2016 – Eine Auswertung des Deutschen Arzneiprüfungsinstitutes e. V. (DAPI)

Evaluation of pharmaceutical concerns in Germany: frequency and potential reasons

Medication adherence and persistence according to different antihypertensive drug classes: A retrospective cohort study of 255,500 patients

Can claims data help validating drug risk signals? A case report

Ad hoc-Auswertungen des DAPI. Dokumentation pharmazeutischer Bedenken in Berlin

Hepatitis C - Neue Wirkstoffe im Vergleich

Adherence to Disease Modifying Drugs among Patients with Multiple Sclerosis in Germany: A Retrospective Cohort Study